24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clinical genetics<br />

Methods: Were investigated 78 patients with CF aged from 2 months<br />

to 2 years, 46 boys and 32 girls by mean <strong>of</strong> polymerase chain reaction<br />

(PCR) .<br />

Results: In 64,1% were detected mutations - delTAF508 - in 57,7%<br />

(15,4% homozygous and 42,3% heterozygous), R334W - heterozygous<br />

- 3,8%, N1303K - heterozygous - 1,3%, MetH polymorphism -<br />

homozygous - 1,3% . In all homozygous and in 88% <strong>of</strong> heterozygous<br />

<strong>of</strong> delTAF508 was mentioned pancreatic insufficiency and extremely<br />

severe injury <strong>of</strong> lungs . In 94,3% <strong>of</strong> patients the process starts before<br />

one year . From 8 died patients 75% were homozygous for delTAF508 .<br />

In 35% <strong>of</strong> patients with this mutation was revealed Ps . Aeruginosa,<br />

in 40% <strong>of</strong> patients was hypotrophy . R334W characterized by slow<br />

progression <strong>of</strong> broncho-pulmonary injury and absence <strong>of</strong> pancreatic<br />

insufficiency. In homozygous <strong>of</strong> MetH polymorphism the disease was<br />

slowly progressive, despite early start in 3 months . 12 patients (15,4%)<br />

were older than 18 years . In half f them were delTAF508 mutation<br />

(heterozygous), in 8 .3% - homozygous . In 16,7% mutations were not<br />

identified.<br />

Conclusion . The clinical pattern and prognosis <strong>of</strong> CF depends from<br />

type <strong>of</strong> mutations . The frequency <strong>of</strong> delTAF508 in Moldova is 57,7% .<br />

In 64,1% <strong>of</strong> cases mutations are identifiable. In 47,7% patients was determined<br />

only one mutation from compound with delTAF508, R334W,<br />

N1303K . It diminishes the possibilities <strong>of</strong> prenatal diagnosis and lead<br />

to necessity to wide range <strong>of</strong> major mutations <strong>of</strong> causal gene .<br />

P01.033<br />

Association <strong>of</strong> polymorphism in the endothelial nitric oxide<br />

syntase gene and clinical features in Russian cF patients<br />

homozygous for F508del mutation<br />

E. E. Tymkovskaya, N. V. Petrova, N. J. Kashirskaya, R. A. Zinchenko;<br />

Research Center for Medical <strong>Genetics</strong>, Moscow, Russian Federation.<br />

The association <strong>of</strong> 27 b .p .VNTR polymorphism in 4 intron <strong>of</strong> eNOS<br />

gene and the clinical features <strong>of</strong> cystic fibrosis was investigated in 101<br />

Russian CF patients homozygous for F508del mutation . All patients<br />

were subdivided for groups according to their eNOS genotype, the<br />

first group - A/A and A/B genotypes (33 patients); the second group<br />

- B/B genotypes (68 patients) . The age <strong>of</strong> onset <strong>of</strong> lung and intestinal<br />

disease symptoms, the age <strong>of</strong> diagnosis, severity <strong>of</strong> disease progression,<br />

FVC index, height-weight indexes, colonization by S.aureus and<br />

P.aeruginosa and other microorganisms, hepatobiliary disease, meconium<br />

ileus and distal intestinal obstructive syndrome in anamneses<br />

were evaluated. FVC index was significant lower in patients with<br />

A/A and A/B eNOS genotypes (69,37±4,09%) than patients with B/B<br />

genotype (80,57±3,31%; p=0,032) . Liver cirrhosis was more frequent<br />

among patients with B/B eNOS genotype (22,1%) than in patients with<br />

A/A and A/B eNOS genotypes (6,1%; p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!